P Narasimhan. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Administration, OralAnticoagulants/pharmacologyBlood Coagulation Disorders/complicationsBlood Coagulation Factors/biosynthesisBlood Coagulation TestsBlood Platelets/drug effectsCerebral ArteriesDose-Response Relationship, DrugHeparin/administration & dosageHeparin/therapeutic useHumansLeg/blood supplyMigraine Disorders/bloodMigraine Disorders/complicationsMigraine Disorders/drug therapyThrombophlebitis/complicationsThrombophlebitis/drug therapyVasodilator Agents/pharmacologyWarfarin/administration & dosageWarfarin/pharmacologyWarfarin/therapeutic use
Substances： See more » AnticoagulantsBlood Coagulation FactorsVasodilator AgentsWarfarinHeparin
Year: 1974 PMID： 4139440 DOI： 10.1016/s0140-6736(74)90905-2
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321